Global Neuromodulation Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Neuromodulation Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Neuromodulation Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pain Management accounting for % of the Neuromodulation Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Deep Brain Stimulation (DBS) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Neuromodulation Devices include Medtronic, Boston Scientific, Abbott, LivaNova, and Nevro, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Neuromodulation Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Neuromodulation Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices, with price, sales, revenue and global market share of Neuromodulation Devices from 2019 to 2022.
Chapter 3, the Neuromodulation Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Neuromodulation Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuromodulation Devices.
Chapter 13, 14, and 15, to describe Neuromodulation Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Neuromodulation Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pain Management accounting for % of the Neuromodulation Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Deep Brain Stimulation (DBS) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Neuromodulation Devices include Medtronic, Boston Scientific, Abbott, LivaNova, and Nevro, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Neuromodulation Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Deep Brain Stimulation (DBS)
- Spinal Cord Stimulation (SCS)
- Vagus Nerve Stimulation (VNS)
- Sacral Nerve Stimulation (SNS)
- Gastric Electrical Stimulation (GES)
- Pain Management
- Parkinson’s Disease
- Urinary and Fecal Incontinence
- Epilepsy
- Gastroparesis
- Other
- Medtronic
- Boston Scientific
- Abbott
- LivaNova
- Nevro
- NeuroPace
- Beijing Pins
- Synapse Biomedical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Neuromodulation Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices, with price, sales, revenue and global market share of Neuromodulation Devices from 2019 to 2022.
Chapter 3, the Neuromodulation Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Neuromodulation Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuromodulation Devices.
Chapter 13, 14, and 15, to describe Neuromodulation Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Neuromodulation Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuromodulation Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Deep Brain Stimulation (DBS)
1.2.3 Spinal Cord Stimulation (SCS)
1.2.4 Vagus Nerve Stimulation (VNS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Gastric Electrical Stimulation (GES)
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuromodulation Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pain Management
1.3.3 Parkinson’s Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Other
1.4 Global Neuromodulation Devices Market Size & Forecast
1.4.1 Global Neuromodulation Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Neuromodulation Devices Sales in Volume (2017-2028)
1.4.3 Global Neuromodulation Devices Price (2017-2028)
1.5 Global Neuromodulation Devices Production Capacity Analysis
1.5.1 Global Neuromodulation Devices Total Production Capacity (2017-2028)
1.5.2 Global Neuromodulation Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neuromodulation Devices Market Drivers
1.6.2 Neuromodulation Devices Market Restraints
1.6.3 Neuromodulation Devices Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Neuromodulation Devices Product and Services
2.1.4 Medtronic Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Neuromodulation Devices Product and Services
2.2.4 Boston Scientific Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Neuromodulation Devices Product and Services
2.3.4 Abbott Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 LivaNova
2.4.1 LivaNova Details
2.4.2 LivaNova Major Business
2.4.3 LivaNova Neuromodulation Devices Product and Services
2.4.4 LivaNova Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Nevro
2.5.1 Nevro Details
2.5.2 Nevro Major Business
2.5.3 Nevro Neuromodulation Devices Product and Services
2.5.4 Nevro Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 NeuroPace
2.6.1 NeuroPace Details
2.6.2 NeuroPace Major Business
2.6.3 NeuroPace Neuromodulation Devices Product and Services
2.6.4 NeuroPace Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Beijing Pins
2.7.1 Beijing Pins Details
2.7.2 Beijing Pins Major Business
2.7.3 Beijing Pins Neuromodulation Devices Product and Services
2.7.4 Beijing Pins Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Synapse Biomedical
2.8.1 Synapse Biomedical Details
2.8.2 Synapse Biomedical Major Business
2.8.3 Synapse Biomedical Neuromodulation Devices Product and Services
2.8.4 Synapse Biomedical Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NEUROMODULATION DEVICES BREAKDOWN DATA BY MANUFACTURER
3.1 Global Neuromodulation Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Neuromodulation Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Neuromodulation Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Neuromodulation Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Neuromodulation Devices Manufacturer Market Share in 2021
3.5 Global Neuromodulation Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Neuromodulation Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Neuromodulation Devices Market Size by Region
4.1.1 Global Neuromodulation Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Neuromodulation Devices Revenue by Region (2017-2028)
4.2 North America Neuromodulation Devices Revenue (2017-2028)
4.3 Europe Neuromodulation Devices Revenue (2017-2028)
4.4 Asia-Pacific Neuromodulation Devices Revenue (2017-2028)
4.5 South America Neuromodulation Devices Revenue (2017-2028)
4.6 Middle East and Africa Neuromodulation Devices Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Neuromodulation Devices Sales in Volume by Type (2017-2028)
5.2 Global Neuromodulation Devices Revenue by Type (2017-2028)
5.3 Global Neuromodulation Devices Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Neuromodulation Devices Sales in Volume by Application (2017-2028)
6.2 Global Neuromodulation Devices Revenue by Application (2017-2028)
6.3 Global Neuromodulation Devices Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Neuromodulation Devices Sales by Type (2017-2028)
7.2 North America Neuromodulation Devices Sales by Application (2017-2028)
7.3 North America Neuromodulation Devices Market Size by Country
7.3.1 North America Neuromodulation Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Neuromodulation Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Neuromodulation Devices Sales by Type (2017-2028)
8.2 Europe Neuromodulation Devices Sales by Application (2017-2028)
8.3 Europe Neuromodulation Devices Market Size by Country
8.3.1 Europe Neuromodulation Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Neuromodulation Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Neuromodulation Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Neuromodulation Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Neuromodulation Devices Market Size by Region
9.3.1 Asia-Pacific Neuromodulation Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Neuromodulation Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Neuromodulation Devices Sales by Type (2017-2028)
10.2 South America Neuromodulation Devices Sales by Application (2017-2028)
10.3 South America Neuromodulation Devices Market Size by Country
10.3.1 South America Neuromodulation Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Neuromodulation Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Neuromodulation Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Neuromodulation Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Neuromodulation Devices Market Size by Country
11.3.1 Middle East & Africa Neuromodulation Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Neuromodulation Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Neuromodulation Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Neuromodulation Devices
12.3 Neuromodulation Devices Production Process
12.4 Neuromodulation Devices Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Neuromodulation Devices Typical Distributors
13.3 Neuromodulation Devices Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Neuromodulation Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuromodulation Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Deep Brain Stimulation (DBS)
1.2.3 Spinal Cord Stimulation (SCS)
1.2.4 Vagus Nerve Stimulation (VNS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Gastric Electrical Stimulation (GES)
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuromodulation Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pain Management
1.3.3 Parkinson’s Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Other
1.4 Global Neuromodulation Devices Market Size & Forecast
1.4.1 Global Neuromodulation Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Neuromodulation Devices Sales in Volume (2017-2028)
1.4.3 Global Neuromodulation Devices Price (2017-2028)
1.5 Global Neuromodulation Devices Production Capacity Analysis
1.5.1 Global Neuromodulation Devices Total Production Capacity (2017-2028)
1.5.2 Global Neuromodulation Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neuromodulation Devices Market Drivers
1.6.2 Neuromodulation Devices Market Restraints
1.6.3 Neuromodulation Devices Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Neuromodulation Devices Product and Services
2.1.4 Medtronic Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Neuromodulation Devices Product and Services
2.2.4 Boston Scientific Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Neuromodulation Devices Product and Services
2.3.4 Abbott Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 LivaNova
2.4.1 LivaNova Details
2.4.2 LivaNova Major Business
2.4.3 LivaNova Neuromodulation Devices Product and Services
2.4.4 LivaNova Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Nevro
2.5.1 Nevro Details
2.5.2 Nevro Major Business
2.5.3 Nevro Neuromodulation Devices Product and Services
2.5.4 Nevro Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 NeuroPace
2.6.1 NeuroPace Details
2.6.2 NeuroPace Major Business
2.6.3 NeuroPace Neuromodulation Devices Product and Services
2.6.4 NeuroPace Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Beijing Pins
2.7.1 Beijing Pins Details
2.7.2 Beijing Pins Major Business
2.7.3 Beijing Pins Neuromodulation Devices Product and Services
2.7.4 Beijing Pins Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Synapse Biomedical
2.8.1 Synapse Biomedical Details
2.8.2 Synapse Biomedical Major Business
2.8.3 Synapse Biomedical Neuromodulation Devices Product and Services
2.8.4 Synapse Biomedical Neuromodulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NEUROMODULATION DEVICES BREAKDOWN DATA BY MANUFACTURER
3.1 Global Neuromodulation Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Neuromodulation Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Neuromodulation Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Neuromodulation Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Neuromodulation Devices Manufacturer Market Share in 2021
3.5 Global Neuromodulation Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Neuromodulation Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Neuromodulation Devices Market Size by Region
4.1.1 Global Neuromodulation Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Neuromodulation Devices Revenue by Region (2017-2028)
4.2 North America Neuromodulation Devices Revenue (2017-2028)
4.3 Europe Neuromodulation Devices Revenue (2017-2028)
4.4 Asia-Pacific Neuromodulation Devices Revenue (2017-2028)
4.5 South America Neuromodulation Devices Revenue (2017-2028)
4.6 Middle East and Africa Neuromodulation Devices Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Neuromodulation Devices Sales in Volume by Type (2017-2028)
5.2 Global Neuromodulation Devices Revenue by Type (2017-2028)
5.3 Global Neuromodulation Devices Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Neuromodulation Devices Sales in Volume by Application (2017-2028)
6.2 Global Neuromodulation Devices Revenue by Application (2017-2028)
6.3 Global Neuromodulation Devices Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Neuromodulation Devices Sales by Type (2017-2028)
7.2 North America Neuromodulation Devices Sales by Application (2017-2028)
7.3 North America Neuromodulation Devices Market Size by Country
7.3.1 North America Neuromodulation Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Neuromodulation Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Neuromodulation Devices Sales by Type (2017-2028)
8.2 Europe Neuromodulation Devices Sales by Application (2017-2028)
8.3 Europe Neuromodulation Devices Market Size by Country
8.3.1 Europe Neuromodulation Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Neuromodulation Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Neuromodulation Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Neuromodulation Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Neuromodulation Devices Market Size by Region
9.3.1 Asia-Pacific Neuromodulation Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Neuromodulation Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Neuromodulation Devices Sales by Type (2017-2028)
10.2 South America Neuromodulation Devices Sales by Application (2017-2028)
10.3 South America Neuromodulation Devices Market Size by Country
10.3.1 South America Neuromodulation Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Neuromodulation Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Neuromodulation Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Neuromodulation Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Neuromodulation Devices Market Size by Country
11.3.1 Middle East & Africa Neuromodulation Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Neuromodulation Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Neuromodulation Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Neuromodulation Devices
12.3 Neuromodulation Devices Production Process
12.4 Neuromodulation Devices Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Neuromodulation Devices Typical Distributors
13.3 Neuromodulation Devices Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Neuromodulation Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Neuromodulation Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Neuromodulation Devices Product and Services
Table 6. Medtronic Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 8. Boston Scientific Major Business
Table 9. Boston Scientific Neuromodulation Devices Product and Services
Table 10. Boston Scientific Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Abbott Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Major Business
Table 13. Abbott Neuromodulation Devices Product and Services
Table 14. Abbott Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. LivaNova Basic Information, Manufacturing Base and Competitors
Table 16. LivaNova Major Business
Table 17. LivaNova Neuromodulation Devices Product and Services
Table 18. LivaNova Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Nevro Basic Information, Manufacturing Base and Competitors
Table 20. Nevro Major Business
Table 21. Nevro Neuromodulation Devices Product and Services
Table 22. Nevro Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. NeuroPace Basic Information, Manufacturing Base and Competitors
Table 24. NeuroPace Major Business
Table 25. NeuroPace Neuromodulation Devices Product and Services
Table 26. NeuroPace Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Beijing Pins Basic Information, Manufacturing Base and Competitors
Table 28. Beijing Pins Major Business
Table 29. Beijing Pins Neuromodulation Devices Product and Services
Table 30. Beijing Pins Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table 32. Synapse Biomedical Major Business
Table 33. Synapse Biomedical Neuromodulation Devices Product and Services
Table 34. Synapse Biomedical Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Neuromodulation Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Neuromodulation Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Neuromodulation Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Neuromodulation Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Neuromodulation Devices Production Site of Key Manufacturer
Table 40. Neuromodulation Devices New Entrant and Capacity Expansion Plans
Table 41. Neuromodulation Devices Mergers & Acquisitions in the Past Five Years
Table 42. Global Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
Table 43. Global Neuromodulation Devices Sales by Region (2023-2028) & (K Units)
Table 44. Global Neuromodulation Devices Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Neuromodulation Devices Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 47. Global Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 48. Global Neuromodulation Devices Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Neuromodulation Devices Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Neuromodulation Devices Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Neuromodulation Devices Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 53. Global Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 54. Global Neuromodulation Devices Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Neuromodulation Devices Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Neuromodulation Devices Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Neuromodulation Devices Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 59. North America Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 60. North America Neuromodulation Devices Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Neuromodulation Devices Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 63. North America Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 64. North America Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 65. North America Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 66. Europe Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 67. Europe Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 68. Europe Neuromodulation Devices Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Neuromodulation Devices Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 71. Europe Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 72. Europe Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 73. Europe Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Neuromodulation Devices Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Neuromodulation Devices Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Neuromodulation Devices Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 82. South America Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 83. South America Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 84. South America Neuromodulation Devices Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Neuromodulation Devices Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 87. South America Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 88. South America Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 89. South America Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Neuromodulation Devices Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Neuromodulation Devices Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Neuromodulation Devices Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 98. Neuromodulation Devices Raw Material
Table 99. Key Manufacturers of Neuromodulation Devices Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Neuromodulation Devices Typical Distributors
Table 103. Neuromodulation Devices Typical Customers
Table 1. Global Neuromodulation Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Neuromodulation Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Neuromodulation Devices Product and Services
Table 6. Medtronic Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 8. Boston Scientific Major Business
Table 9. Boston Scientific Neuromodulation Devices Product and Services
Table 10. Boston Scientific Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Abbott Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Major Business
Table 13. Abbott Neuromodulation Devices Product and Services
Table 14. Abbott Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. LivaNova Basic Information, Manufacturing Base and Competitors
Table 16. LivaNova Major Business
Table 17. LivaNova Neuromodulation Devices Product and Services
Table 18. LivaNova Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Nevro Basic Information, Manufacturing Base and Competitors
Table 20. Nevro Major Business
Table 21. Nevro Neuromodulation Devices Product and Services
Table 22. Nevro Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. NeuroPace Basic Information, Manufacturing Base and Competitors
Table 24. NeuroPace Major Business
Table 25. NeuroPace Neuromodulation Devices Product and Services
Table 26. NeuroPace Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Beijing Pins Basic Information, Manufacturing Base and Competitors
Table 28. Beijing Pins Major Business
Table 29. Beijing Pins Neuromodulation Devices Product and Services
Table 30. Beijing Pins Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table 32. Synapse Biomedical Major Business
Table 33. Synapse Biomedical Neuromodulation Devices Product and Services
Table 34. Synapse Biomedical Neuromodulation Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Neuromodulation Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Neuromodulation Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Neuromodulation Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Neuromodulation Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Neuromodulation Devices Production Site of Key Manufacturer
Table 40. Neuromodulation Devices New Entrant and Capacity Expansion Plans
Table 41. Neuromodulation Devices Mergers & Acquisitions in the Past Five Years
Table 42. Global Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
Table 43. Global Neuromodulation Devices Sales by Region (2023-2028) & (K Units)
Table 44. Global Neuromodulation Devices Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Neuromodulation Devices Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 47. Global Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 48. Global Neuromodulation Devices Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Neuromodulation Devices Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Neuromodulation Devices Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Neuromodulation Devices Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 53. Global Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 54. Global Neuromodulation Devices Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Neuromodulation Devices Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Neuromodulation Devices Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Neuromodulation Devices Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 59. North America Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 60. North America Neuromodulation Devices Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Neuromodulation Devices Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 63. North America Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 64. North America Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 65. North America Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 66. Europe Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 67. Europe Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 68. Europe Neuromodulation Devices Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Neuromodulation Devices Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 71. Europe Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 72. Europe Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 73. Europe Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Neuromodulation Devices Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Neuromodulation Devices Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Neuromodulation Devices Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 82. South America Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 83. South America Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 84. South America Neuromodulation Devices Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Neuromodulation Devices Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 87. South America Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 88. South America Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 89. South America Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Neuromodulation Devices Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Neuromodulation Devices Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Neuromodulation Devices Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 98. Neuromodulation Devices Raw Material
Table 99. Key Manufacturers of Neuromodulation Devices Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Neuromodulation Devices Typical Distributors
Table 103. Neuromodulation Devices Typical Customers
LIST OF FIGURES
Figure 1. Neuromodulation Devices Picture
Figure 2. Global Neuromodulation Devices Revenue Market Share by Type in 2021
Figure 3. Deep Brain Stimulation (DBS)
Figure 4. Spinal Cord Stimulation (SCS)
Figure 5. Vagus Nerve Stimulation (VNS)
Figure 6. Sacral Nerve Stimulation (SNS)
Figure 7. Gastric Electrical Stimulation (GES)
Figure 8. Global Neuromodulation Devices Revenue Market Share by Application in 2021
Figure 9. Pain Management
Figure 10. Parkinson’s Disease
Figure 11. Urinary and Fecal Incontinence
Figure 12. Epilepsy
Figure 13. Gastroparesis
Figure 14. Other
Figure 15. Global Neuromodulation Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Neuromodulation Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Neuromodulation Devices Sales (2017-2028) & (K Units)
Figure 18. Global Neuromodulation Devices Price (2017-2028) & (US$/Unit)
Figure 19. Global Neuromodulation Devices Production Capacity (2017-2028) & (K Units)
Figure 20. Global Neuromodulation Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Neuromodulation Devices Market Drivers
Figure 22. Neuromodulation Devices Market Restraints
Figure 23. Neuromodulation Devices Market Trends
Figure 24. Global Neuromodulation Devices Sales Market Share by Manufacturer in 2021
Figure 25. Global Neuromodulation Devices Revenue Market Share by Manufacturer in 2021
Figure 26. Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Neuromodulation Devices Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Neuromodulation Devices Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Neuromodulation Devices Sales Market Share by Region (2017-2028)
Figure 30. Global Neuromodulation Devices Revenue Market Share by Region (2017-2028)
Figure 31. North America Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 32. Europe Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 34. South America Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 36. Global Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 37. Global Neuromodulation Devices Revenue Market Share by Type (2017-2028)
Figure 38. Global Neuromodulation Devices Price by Type (2017-2028) & (US$/Unit)
Figure 39. Global Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 40. Global Neuromodulation Devices Revenue Market Share by Application (2017-2028)
Figure 41. Global Neuromodulation Devices Price by Application (2017-2028) & (US$/Unit)
Figure 42. North America Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 43. North America Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 44. North America Neuromodulation Devices Sales Market Share by Country (2017-2028)
Figure 45. North America Neuromodulation Devices Revenue Market Share by Country (2017-2028)
Figure 46. United States Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 50. Europe Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 51. Europe Neuromodulation Devices Sales Market Share by Country (2017-2028)
Figure 52. Europe Neuromodulation Devices Revenue Market Share by Country (2017-2028)
Figure 53. Germany Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Neuromodulation Devices Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Neuromodulation Devices Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Neuromodulation Devices Revenue Market Share by Region (2017-2028)
Figure 62. China Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 69. South America Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 70. South America Neuromodulation Devices Sales Market Share by Country (2017-2028)
Figure 71. South America Neuromodulation Devices Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Neuromodulation Devices Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Neuromodulation Devices Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Neuromodulation Devices in 2021
Figure 83. Manufacturing Process Analysis of Neuromodulation Devices
Figure 84. Neuromodulation Devices Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Neuromodulation Devices Picture
Figure 2. Global Neuromodulation Devices Revenue Market Share by Type in 2021
Figure 3. Deep Brain Stimulation (DBS)
Figure 4. Spinal Cord Stimulation (SCS)
Figure 5. Vagus Nerve Stimulation (VNS)
Figure 6. Sacral Nerve Stimulation (SNS)
Figure 7. Gastric Electrical Stimulation (GES)
Figure 8. Global Neuromodulation Devices Revenue Market Share by Application in 2021
Figure 9. Pain Management
Figure 10. Parkinson’s Disease
Figure 11. Urinary and Fecal Incontinence
Figure 12. Epilepsy
Figure 13. Gastroparesis
Figure 14. Other
Figure 15. Global Neuromodulation Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Neuromodulation Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Neuromodulation Devices Sales (2017-2028) & (K Units)
Figure 18. Global Neuromodulation Devices Price (2017-2028) & (US$/Unit)
Figure 19. Global Neuromodulation Devices Production Capacity (2017-2028) & (K Units)
Figure 20. Global Neuromodulation Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Neuromodulation Devices Market Drivers
Figure 22. Neuromodulation Devices Market Restraints
Figure 23. Neuromodulation Devices Market Trends
Figure 24. Global Neuromodulation Devices Sales Market Share by Manufacturer in 2021
Figure 25. Global Neuromodulation Devices Revenue Market Share by Manufacturer in 2021
Figure 26. Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Neuromodulation Devices Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Neuromodulation Devices Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Neuromodulation Devices Sales Market Share by Region (2017-2028)
Figure 30. Global Neuromodulation Devices Revenue Market Share by Region (2017-2028)
Figure 31. North America Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 32. Europe Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 34. South America Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Neuromodulation Devices Revenue (2017-2028) & (USD Million)
Figure 36. Global Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 37. Global Neuromodulation Devices Revenue Market Share by Type (2017-2028)
Figure 38. Global Neuromodulation Devices Price by Type (2017-2028) & (US$/Unit)
Figure 39. Global Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 40. Global Neuromodulation Devices Revenue Market Share by Application (2017-2028)
Figure 41. Global Neuromodulation Devices Price by Application (2017-2028) & (US$/Unit)
Figure 42. North America Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 43. North America Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 44. North America Neuromodulation Devices Sales Market Share by Country (2017-2028)
Figure 45. North America Neuromodulation Devices Revenue Market Share by Country (2017-2028)
Figure 46. United States Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 50. Europe Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 51. Europe Neuromodulation Devices Sales Market Share by Country (2017-2028)
Figure 52. Europe Neuromodulation Devices Revenue Market Share by Country (2017-2028)
Figure 53. Germany Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Neuromodulation Devices Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Neuromodulation Devices Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Neuromodulation Devices Revenue Market Share by Region (2017-2028)
Figure 62. China Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 69. South America Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 70. South America Neuromodulation Devices Sales Market Share by Country (2017-2028)
Figure 71. South America Neuromodulation Devices Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Neuromodulation Devices Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Neuromodulation Devices Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Neuromodulation Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Neuromodulation Devices in 2021
Figure 83. Manufacturing Process Analysis of Neuromodulation Devices
Figure 84. Neuromodulation Devices Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source
